JPRN-jRCT1041190002
Recruiting
未知
Investigation of Influence of SGLT2 inhibitor on myocardial fatty acid metabolism using BMIPP SPECT - ISMFAM
Kumazaki Setsuo0 sites40 target enrollmentApril 4, 2019
Conditionstype 2 diabetes
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- type 2 diabetes
- Sponsor
- Kumazaki Setsuo
- Enrollment
- 40
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •type 2 diabetic patients with cardiac dysfunction, diastolic dysfunction or cardiac abnormalities
Exclusion Criteria
- •Patients who did not meet the selection criteria
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
The inhibitory effects of the SGLT2 inhibitor for progression of diabetic nephropathy, in the patients with type 2 diabetes in Japan.diabetic nephropathy in type 2 diabetes mellitusJPRN-UMIN000016754Saitama Medical Center, Saitama Medical University50
Active, not recruiting
Phase 1
The REFORM TrialType 2 diabetes and Heart FailureTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]EUCTR2014-002742-42-GBniversity of Dundee/ NHS Tayside56
Completed
Not Applicable
Effects of treatment with SGLT2 inhibitor on the initiation of continuous positive airway pressure therapy in type 2 diabetic patients with obstructive sleep apnea syndromeType 2 diabetesJPRN-UMIN000045226Akishima Clinic16
Not yet recruiting
Not Applicable
Observational Study of the effect of SGLT2 inhibitor on Glycemic Control Indicesdiabetes mellitusJPRN-UMIN000050228agoya University4,250
Not yet recruiting
Not Applicable
Influence of SGLT2 inhibitors on the efficiency of peritoneal dialysisChronic kidney disease under peritoneal dialysisJPRN-UMIN000049848International University of Health and Welfare10